Completed PHASE4 INTERVENTIONAL 3-arm NCT01722409

A Better Choice for Patients Undergoing Endovascular Coil Embolization

Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization

Sponsor: China Medical University, China

Conditions Intracranial Aneurysms

Interventions sevoflurane and 0.5 μg/kg dexmedetomidine sevoflurane and 1 μg/kg dexmedetomidine

Updated 5 times since 2017 Last updated: Jun 23, 2015 Started: Dec 31, 2012 Primary completion: Feb 28, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Intracranial Aneurysms, this trial is completed. The trial is conducted by China Medical University, China and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University, China

Data source: China Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenyang, China